TEAM: Testosterone Supplementation and Exercise in Elderly Men

PHASE2CompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Healthy
Interventions
DRUG

LowT

Low Dose Testosterone Group applies one 2.5 gm active packet and one placebo packet, titrated to a target blood range of 400-550 pg/ml)during the first 12 weeks. Total exposure duration is 52 weeks.

BEHAVIORAL

Resistance Training

Weight training 45-60 minutes 3 times per week

DRUG

Placebo

2.5 gm gel packets applied once daily. Sham adjustments made during the first 12 weeks. Duration is 52 weeks.

DRUG

HighT

High Dose Testosterone Group applies two 2.5 gm active packets, titrated to a target blood range of 600-1000 pg/ml)during the first 12 weeks. Total exposure duration is 52 weeks.

Trial Locations (1)

80262

University of Colorado Health Sciences Center, Denver

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Colorado, Denver

OTHER

NCT00112151 - TEAM: Testosterone Supplementation and Exercise in Elderly Men | Biotech Hunter | Biotech Hunter